» Authors » Chiara Fraccaro

Chiara Fraccaro

Explore the profile of Chiara Fraccaro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 143
Citations 1570
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Palmerini T, Saia F, Bruno A, Kim W, Iadanza A, Ghetti G, et al.
J Invasive Cardiol . 2025 Feb; PMID: 39993270
Objectives: The authors compared the risk of cerebrovascular events (CVE) with self-expanding vales (SEV) vs balloon-expandable valves (BEV) in patients with or without peripheral artery disease (PAD), stratified by the...
2.
Tarantini G, Fraccaro C, Porzionato A, van Mieghem N, Treede H, Shammas N, et al.
Am J Cardiol . 2025 Jan; 241:77-83. PMID: 39870321
Advances in personalized medicine and Systems Biology have introduced probabilistic models and error discovery to cardiovascular care, aiding disease prevention and procedural planning. However, clinical application faces cultural, technical, and...
3.
Rizzo S, De Gaspari M, Basso C, Fraccaro C, Thiene G
Cardiovasc Pathol . 2025 Jan; 76:107722. PMID: 39855436
Foramen ovale plays a key role in foetal circulation, however it may remain patent after birth throughout the life. Its patency is so frequent in healthy people (27-35 %), such...
4.
Bay B, Gitto M, Sartori S, Vogel B, Tchetche D, Petronio A, et al.
Catheter Cardiovasc Interv . 2025 Jan; 105(4):891-899. PMID: 39776285
Background: Limited data exist on the impact of polyvascular disease (PolyVD) on clinical outcomes in female patients undergoing transcatheter aortic valve replacement (TAVR). We therefore sought to investigate clinical outcomes...
5.
Fraccaro C, Iannaccone M, Boccuzzi G, Boscolo Bozza A, Carrafiello G, DellAmore A, et al.
G Ital Cardiol (Rome) . 2024 Nov; 25(11 Suppl 3):5S-23S. PMID: 39588601
Pulmonary embolism (PE) is commonly treated primarily with pharmacological therapy, while advanced reperfusion therapies (transcatheter or surgical) are considered only in cases of contraindications or failure of standard therapies. Treatment...
6.
Masiero G, Arturi F, Soramio E, Fovino L, Fabris T, Cardaioli F, et al.
Am J Cardiol . 2024 Nov; 234:99-106. PMID: 39572265
Right-sided cardiac catheterization (RHC) is selectively recommended in mitral valve transcatheter edge-to-edge (M-TEER) workup because right ventricle (RV) hemodynamic parameters predict adverse outcomes. This study examines the impact of RV...
7.
Buono A, Zito A, Kim W, Fabris T, De Biase C, Bellamoli M, et al.
JACC Cardiovasc Interv . 2024 Nov; PMID: 39570223
Background: Balloon-expandable valves (BEVs) and self-expanding valves (SEVs) have different features that may impact the outcomes of patients with Sievers type 1 bicuspid aortic valve (BAV) stenosis undergoing transcatheter aortic...
8.
Cardaioli F, Fovino L, Fabris T, Masiero G, Arturi F, Panza A, et al.
EuroIntervention . 2024 Nov; 20(22):1380-1389. PMID: 39552481
Background: In patients undergoing transcatheter aortic valve implantation (TAVI), the presence of a low-flow, low-gradient (LFLG) status has been associated with higher mortality at short-term follow-up. Aims: We aimed to...
9.
Di Muro F, Vogel B, Sartori S, Tchetche D, Feng Y, Petronio A, et al.
Am J Cardiol . 2024 Nov; 236():56-63. PMID: 39522578
Limited evidence exists concerning the prognostic impact of baseline left ventricular ejection fraction (LVEF) on outcomes among women undergoing transcatheter aortic valve implantation (TAVI), which we aimed to investigate in...
10.
Buono A, De Biase C, Fabris T, Bellamoli M, Kim W, Montarello N, et al.
Int J Cardiol . 2024 Sep; 417():132569. PMID: 39303924
Background: Raphe-type bicuspid aortic valve (BAV) is a potential hostile scenario in trans-catheter aortic valve replacement (TAVR) due to pronounced calcium burden, possibly associated with tapered valve configuration. Trans-Catheter heart...